Form D · Pharmaceuticals

GLYCOMIMETICS INC

Gaithersburg, MD · CIK 0001253689

Offering snapshot reported Oct 27, 2010 · SEC filing

Reported sold
$39M
Offering amount: $50M
Investors reported
15
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 20, 2009
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$19.5M$39MNov 4, 2009: $38,979,412.00Nov 4, 2009Oct 27, 2010: $38,979,412.00Oct 27, 2010

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 27, 2010Amendment$38,979,412$0vs Nov 4, 200915SEC filing
Nov 4, 2009Initial$15,315,525No comparison10SEC filing
Nov 4, 2009Initial$38,979,412No comparison15SEC filing
Jul 13, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Security to be acquired, Other
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-56767
The total amount sold is $38,979,412.47, based on purchase price of $1.2686 per share.
Series A-1 Convertible Preferred Stock and underlying common stock upon conversion.

Source: Form D, filed Oct 27, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
John Baldwin Director
M. James Barrett Director
William Gust Director
Michael Henos Director
Rachel King Director, Executive
John Magnani Director, Executive
Helen Thackray Executive
Franklin Top Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
101 Orchard Ridge Drive Suite 1 E
Gaithersburg, MD, 20878